<DOC>
	<DOCNO>NCT02004210</DOCNO>
	<brief_summary>The aim study compare efficacy conventional transarterial chemoembolization ( TACE ) transarterial radioembolization patient unilobar advance hepatocellular carcinoma .</brief_summary>
	<brief_title>A Phase 3 Trial Comparing TACE TARE Unilobar Advanced Hepatocellular Carcinoma</brief_title>
	<detailed_description>Potentially curative treatment hepatocellular carcinoma ( HCC ) include surgical resection , liver transplantation , local ablative therapy . However , HCC patient diagnose advanced stage Korea . Unresectable advance HCCs suitable curative therapy . For patient , optimal treatment remain largely controversial . As palliative treatment , benefit transarterial chemoembolization ( TACE ) show patient unresectable HCC several trial . Recently , transarterial radioembolization ( TARE ) introduce treatment advanced HCC . However , efficacy TARE compare TACE uncertain . The aim study compare efficacy conventional transarterial chemoembolization ( TACE ) transarterial radioembolization patient unilobar advance hepatocellular carcinoma .</detailed_description>
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>Patients clinical histological diagnosis HCC base guideline AJCC Patients advance HCC unilobar advanaced involvement : right lobe ± S4 segment leave lobe ± S4 segment ) Patients single large HCC multinodular HCC Single &amp; 5cm &lt; size &lt; 15cm 25 nodule &amp; maximal size 415cm &amp; sum diameter ≦ 25cm Infiltrative type &amp; unilobular involvement liver MRI Segmental lobar portal vein invasion include . Age : 20 year 80 year ECOG Performance Status 0 2 ChildPugh class A ( ChildPugh score 56 ) , B ( CP score 7 ) Adequate bone marrow , liver function assess follow laboratory requirement conduct within 7 day prior screen : WBC count ≧ 1,000/mm3 Absolute neutrophil count &gt; 500/mm3 Hb ≧ 7.0 g/dL Platelet count &gt; 100,000 /mm3 Bilirubin ≦ 3 mg/dL Adequate clotting function : INR ≦ 2.3 ≦ 6sec ChildPugh score ≧ 8 ECOG Performance Status ≧ 3 Patients chronic kidney disease serum creatinine ≥ 1.2 mg/dL History organ allograft Patients uncontrolled comorbidity need treatment Patients receive prior systemic chemotherapy Patients receive Capecitabine within 8 week Patients extrahepatic metastasis Main portal vein invasion Patients lymph node metastasis Bilobar involvement Bulk disease ( Tumor volume &gt; 70 % target liver volume , tumor nodule numerous count ) Pregnancy</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>April 2016</verification_date>
	<keyword>transarterial chemoembolization</keyword>
	<keyword>transarterial radioembolization</keyword>
	<keyword>advanced hepatocellular carcinoma</keyword>
</DOC>